英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
Nociceptin (1-13), amide
|
178064-02-3 |
PHE-GLY-GLY-PHE-THR-GLY-ALA-ARG-LYS-SER-ALA-ARG-LYS-NH2
|
|
C61H100N22O15 |
1381.59 | |
FOR-MET-LEU-PHE-LYS-OH
|
67247-11-4 |
FOR-MET-LEU-PHE-LYS-OH
|
FOR-MET-LEU-PHE-LYS
|
C27H43N5O6S |
565.73 | |
N-CBZ-PHE-ARG 7-AMIDO-4-METHYLCOUMARIN HYDROChloride
|
65147-22-0 |
Z-PHE-ARG 7-AMIDO-4-METHYLCOUMARIN HYDROCHLORIDE
|
Z-苯丙胺酰-精氨酸-7-氨基-4-甲基香豆素盐酸盐;Z-苯丙胺酰-精氨酸-7-氨基-4-甲基香豆素盐酸盐
|
C33H37ClN6O6 |
649.14 | |
NEUROTENSIN (8-13)
|
60482-95-3 |
ARG-ARG-PRO-TYR-ILE-LEU
|
AC-ARG-ARG-PRO-TYR-ILE-LEU: AC-RRPYIL;NEUROTENSIN (8-13)肽
|
C38H64N12O8 |
816.99 | |
H-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
119019-65-7 |
SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2
|
H-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;CALMODULIN INHIBITORY PEPTIDE;CALMODULIN INHIBITORY PEPTIDE, CONTROL;SALRHYINLITRQRY-NH2;SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-THR-ARG-GLN-ARG-TYR-NH2;NEUROPEPTIDE Y (22-36);NEUROPEPTIDE Y (22-36), PORCINE;NPY (22-36)
|
C85H139N29O21 |
||
H-GLU-ILE-GLY-ASP-GLU-GLU-ASN-SER-ALA-LYS-PHE-PRO-ILE-NH2
|
125934-45-4 |
GLU-ILE-GLY-ASP-GLU-GLU-ASN-SER-ALA-LYS-PHE-PRO-ILE-NH2
|
|
C63H98N16O23 |
1447.55 | |
Neuromedin U-25 (porcine) trifluoroacetate salt
|
312306-89-1 |
GLY-ASN-HIS-TRP-ALA-VAL-GLY-HIS-LEU-MET-NH2: GNHWAVGHLM-NH2
|
|
C141H202N41O38R |
3079.36448 | |
NEUROMEDIN U (RAT)
|
117505-80-3 |
TYR-LYS-VAL-ASN-GLU-TYR-GLN-GLY-PRO-VAL-ALA-PRO-SER-GLY-GLY-PHE-PHE-LEU-PHE-ARG-PRO-ARG-ASN-NH2
|
|
C124H180N34O31 |
2642.97 | |
NEUROMEDIN N
|
92169-45-4 |
LYS-ILE-PRO-TYR-ILE-LEU
|
|
C38H63N7O8 |
745.95 | |
NEUROMEDIN B
|
87096-84-2 |
GLY-ASN-LEU-TRP-ALA-THR-GLY-HIS-PHE-MET-NH2
|
|
C52H73N15O12S |
1132.29 | |
N4-Benzoyl-5'-O-DMT-2'-O-(2-methoxyethyl)cytidine
|
251647-49-1 |
N-苯甲酰基-5'-O-[双(4-甲氧基苯基)苯基甲基]-2'-O-(2-甲氧基乙基)胞苷
|
N-BENZOYL-5'-O-DMTR-2'-O-(2-METHOXYETHYL)-CYTIDINE>95%;N-苯甲酰基-5'-O-[双(4-甲氧基苯基)苯基甲基]-2'-O-(2-甲氧基乙基)胞苷
|
C40H41N3O9 |
708 | |
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-O-(2-methoxyethyl)adenosine
|
251647-48-0 |
N-苯甲酰基-5'-O-[双(4-甲氧基苯基)苯基甲基]-2'-O-(2-甲氧基乙基)腺苷
|
N-苯甲酰基-5'-O-[双(4-甲氧基苯基)苯基甲基]-2'-O-(2-甲氧基乙基)腺苷;N-BENZOYL-5'-O-DMTR-2'-O-(2-METHOXYETHYL)-ADENOSINE>95%
|
C41H41N5O8 |
731.79294 | |
Natamycin
|
7681-93-8 |
纳他霉素
|
那他霉素;纳他霉素(游霉素);食品级纳它霉素;那他霉素(微生物发酵法);那他霉素 制备;游霉素 制备;那他霉素(游霉素);纳他霉素,≥96% ;纳他霉素(标准品)
|
C33H47NO13 |
665.73 | 231-683-5 |
N-Acetyl-Ser-Asp-Lys-Pro
|
127103-11-1 |
戈雷拉肽
|
戈雷拉肽;乙酰基-丝氨酰-天冬氨酰-赖氨酰-脯氨酸
|
C20H33N5O9 |
487.5 | |
N-[9-[(2R,6S)-6-(hydroxymethyl)-2-morpholinyl]-9H-purin-6-yl]-Benzamide
|
139290-78-1 |
(2R-顺式)-N-[9-[6-(羟基甲基)-2-吗啉基]-9H-嘌呤-6-基]苯甲酰胺
|
(2R-顺式)-N-[9-[6-(羟基甲基)-2-吗啉基]-9H-嘌呤-6-基]苯甲酰胺
|
C17H18N6O3 |
354.36322 | |
N-[6,9-dihydro-9-[(2R,6S)-6-(hydroxymethyl)-2-morpholinyl]-6-oxo-1H-purin-2-yl]-2-methyl-Propanamide
|
956139-23-4 |
N-[6,9-二氢-9-[(2R,6S)-6-(羟基甲基)-2-吗啉基]-6-氧代-1H-嘌呤-2-基]-2-甲基-丙酰胺
|
N-[6,9-二氢-9-[(2R,6S)-6-(羟基甲基)-2-吗啉基]-6-氧代-1H-嘌呤-2-基]-2-甲基-丙酰胺
|
C14H20N6O4 |
336.3464 | |
N-(4-Bromobutyl)Phthalimide
|
5394-18-3 |
N-(4-溴丁基)邻苯二甲酰亚胺
|
N-(4-溴丁基)邻苯二甲酰亚胺;N-(4-溴丁基)苯二胺;N-甲基-4-N-[4-(N-邻苯二甲酰亚胺)丁基]氨基邻苯二甲酰亚胺;N-(4-溴丁基)酞酰亚胺;N-(4-溴丁基)邻苯二甲酰亚胺;N-(4-溴丁基)苯邻二甲酰亚胺;N-(4-溴丁基)邻苯二甲酰亚胺 100G
|
C12H12NO2Br |
282.13318 | 226-401-2 |
Myristoyl Pentapeptide-17
|
959610-30-1 |
N2-(1-氧代十四烷基)-L-赖氨酰-L-亮氨酰-L-丙氨酰-L-赖氨酰-L-赖氨酰胺
|
N2-(1-氧代十四烷基)-L-赖氨酰-L-亮氨酰-L-丙氨酰-L-赖氨酰-L-赖氨酰胺;肉豆蔻酸五肽-17;肉豆蔻酰五肽;肉豆蔻酰五肽原液;睫毛肽;肉豆蔻五肽17;肉豆蔻酰基五肽-17;肉豆蔻酰六肽-16
|
C41H81N9O6 |
796.13854 | |
H-GLN-LYS-ARG-PRO-SER-GLN-ARG-SER-LYS-TYR-LEU-OH
|
126768-94-3 |
GLN-LYS-ARG-PRO-SER-GLN-ARG-SER-LYS-TYR-LEU
|
|
C60H103N21O17 |
1390.59 | |
GALFLGFLGAAGSTMGAWSQPKSKRKV
|
395069-92-8 |
39569-92-8
|
GALFLGFLGAAGSTMGAWSQPKSKRKV;H-GLY-ALA-LEU-PHE-LEU-GLY-PHE-LEU-GLY-ALA-ALA-GLY-SER-THR-MET-GLY-ALA-TRP-SER-GLN-PRO-LYS-SER-LYS-ARG-LYS-VAL-OH;MPG, HIV RELATED
|